Dr. Reddy’s Laboratories has launched Bispec (Solifencin Succinate) in India. The drug is used in the management of Over Active Bladder (OAB) and is the best-in-class for OAB and has lesser incidence of dry mouth and constipation.
Usually patients suffering from OAB have a warning time of about 12 seconds; however, Solifencin Succinate helps in increasing this time to about 32 seconds. Warning time is the period between first sensation of urgency and urination in patients with OAB syndrome
Solifencin acts by competitively inhibiting Acetyl choline from binding to cholinergic receptors present in bladder, thereby reducing bladder contractions and improving warning time in over active bladder patients. Solifencin Succinate is highly receptor (M3) specific and has superior pharmacokinetic profile
Bispec is available in tablet form and in dosages of 5 mg and 10 mg.